Cost-effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trial.
C B Okeke OgwuluE V WilliamsJ J ChuA J DevallL E BeesonP HardyVersha CheedS YongzhongL L JonesJ H La Fontaine PapadopoulosR Bender-AtikJ BrewinK HinshawM ChoudharyA AhmedJ NaftalinN NunesA OliverF IzzatK BhatiaI HassanY JeveJ HamiltonS DebsC BottomleyJ RossLinda WatkinsM UnderwoodY CheongC S KumarP GuptaR SmallStewart PringleF S HodgeA ShahidAndrew W HorneS QuenbyI D GallosA CoomarasamyT E RobertsPublished in: BJOG : an international journal of obstetrics and gynaecology (2021)
The combination of mifepristone and misoprostol is more effective and less costly than misoprostol alone for the management of missed miscarriages.